-+ 0.00%
-+ 0.00%
-+ 0.00%

Insight Molecular Diagnostics to showcase GraftAssure at American Transplant Congress

PUBT·06/09/2026 20:06:20
Listen to the news
Insight Molecular Diagnostics to showcase GraftAssure at American Transplant Congress
  • Insight Molecular Diagnostics will highlight its GraftAssure transplant rejection monitoring technology at the American Transplant Congress in Boston, June 20-24.
  • A private reception with transplant physicians and lab directors is scheduled during the meeting to discuss in-house dd-cfDNA testing.
  • Third-party late-breaking head-to-head data on GraftAssureIQ versus a commercial centralized test is set for presentation June 23.
  • Grant winners for an iMDx-ASTS study on in-house versus centralized testing economics will be announced at the conference.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Insight Molecular Diagnostics Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202606091605PRIMZONEFULLFEED9734398) on June 09, 2026, and is solely responsible for the information contained therein.